Linustedastatum
Linustedastatum (Linustedastat; FOR-6219) is an orally active hydroxysteroid 17-beta dehydrogenase 1 (HSD17B1) inhibitor. Linustedastatum can be used for the study of endometriosis[1][2].
Product Specifications
CAS Number
[2254299-48-2]
Product Name Alternative
Linustedastat; FOR-6219; OG-6219
UNSPSC
12352005
Target
17β-HSD
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Endocrinology
Assay Protocol
https://www.medchemexpress.com/linustedastatum.html
Purity
98.10
Solubility
DMSO : ≥ 170 mg/mL
Smiles
C[C@@]12[C@]([C@@H](C/C2=N\O)CCC(NC3=CC=C(C=N3)F)=O)([H])[C@@]4([H])[C@@](CC1)([H])C5=CC=CC(F)=C5CC4
Molecular Formula
C26H29F2N3O2
Molecular Weight
453.52
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-159525/Linustedastatum-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-159525/Linustedastatum-SDS-MedChemExpress.pdf
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
TIGD1, NT (TIGD1, Tigger transposable element-derived protein 1) (MaxLight 750)